questionsmedicales.fr
Maladies du système immunitaire
Maladies auto-immunes
Maladie de Basedow
Ophtalmopathie basedowienne
Ophtalmopathie basedowienne : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Ophtalmopathie
Maladie de Basedow
Thyroïdite
Imagerie par résonance magnétique
Échographie
Thyroïde
Exophtalmie
Diplopie
Paupière
Hormones thyroïdiennes
Anticorps
Thyroïde
Diagnostic différentiel
Exophtalmie
Maladies oculaires
Symptômes
5
Exophtalmie
Sécheresse oculaire
Douleur oculaire
Diplopie
Muscles oculaires
Vision
Vision
Vision floue
Troubles visuels
Paupières
Inflammation
Gonflement
Symptômes
Variabilité
Maladie
Prévention
5
Prévention
Maladie de Basedow
Thyroïde
Tabagisme
Risque
Symptômes
Stress
Gestion du stress
Santé
Examens médicaux
Détection précoce
Santé oculaire
Alimentation
Santé thyroïdienne
Santé oculaire
Traitements
5
Corticostéroïdes
Radiothérapie
Chirurgie
Corticostéroïdes
Inflammation
Symptômes
Chirurgie
Exophtalmie
Vision
Radiothérapie
Tissus orbitaires
Inflammation
Larmes artificielles
Lunettes prismatiques
Traitements non médicamenteux
Complications
5
Complications
Perte de vision
Nerfs optiques
Perte de vision
Récupération
Gravité
Esthétique
Exophtalmie
Paupières
Nerfs optiques
Inflammation
Vision
Complications
Suivi médical
Traitement
Facteurs de risque
5
Facteurs de risque
Hyperthyroïdie
Antécédents familiaux
Antécédents familiaux
Maladies thyroïdiennes
Risque
Stress
Facteurs de risque
Symptômes
Femmes
Risque
Ophtalmopathie
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Ophtalmopathie basedowienne : Questions médicales les plus fréquentes",
"headline": "Ophtalmopathie basedowienne : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Ophtalmopathie basedowienne : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-26",
"dateModified": "2025-03-23",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Ophtalmopathie basedowienne"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Maladie de Basedow",
"url": "https://questionsmedicales.fr/mesh/D006111",
"about": {
"@type": "MedicalCondition",
"name": "Maladie de Basedow",
"code": {
"@type": "MedicalCode",
"code": "D006111",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.111.555"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Ophtalmopathie basedowienne",
"alternateName": "Graves Ophthalmopathy",
"code": {
"@type": "MedicalCode",
"code": "D049970",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Kubra Serbest Ceylanoglu",
"url": "https://questionsmedicales.fr/author/Kubra%20Serbest%20Ceylanoglu",
"affiliation": {
"@type": "Organization",
"name": "University of Health Sciences, Ulucanlar Eye Education and Research Hospital, Ankara, Turkey."
}
},
{
"@type": "Person",
"name": "Emine Malkoc Sen",
"url": "https://questionsmedicales.fr/author/Emine%20Malkoc%20Sen",
"affiliation": {
"@type": "Organization",
"name": "University of Health Sciences, Ulucanlar Eye Education and Research Hospital, Ankara, Turkey."
}
},
{
"@type": "Person",
"name": "Xin Wang",
"url": "https://questionsmedicales.fr/author/Xin%20Wang",
"affiliation": {
"@type": "Organization",
"name": "School of Basic Medical Science, Special Key Laboratory of Ocular Diseases of Guizhou Province, Zunyi Medical University, Zunyi, 563000, China."
}
},
{
"@type": "Person",
"name": "Poupak Fallahi",
"url": "https://questionsmedicales.fr/author/Poupak%20Fallahi",
"affiliation": {
"@type": "Organization",
"name": "Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy."
}
},
{
"@type": "Person",
"name": "Alessandro Antonelli",
"url": "https://questionsmedicales.fr/author/Alessandro%20Antonelli",
"affiliation": {
"@type": "Organization",
"name": "Department of Surgical, Medical and Molecular Pathology and Critical Area, University of Pisa, Pisa, Italy."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Serum prostate specific antigen is a good indicator of prostatic volume in men with benign prostatic hyperplasia.",
"datePublished": "2022-12-15",
"url": "https://questionsmedicales.fr/article/36546488",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.4102/phcfm.v14i1.3736"
}
},
{
"@type": "ScholarlyArticle",
"name": "Granulomatous prostatitis: mimicking locally advanced prostate adenocarcinoma.",
"datePublished": "2023-10-17",
"url": "https://questionsmedicales.fr/article/37850783",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.23750/abm.v94i5.13751"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prostatic Artery Embolization Versus Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia: A Cost-Effectiveness Analysis.",
"datePublished": "2022-08-12",
"url": "https://questionsmedicales.fr/article/35964881",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jvir.2022.08.006"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prostate organogenesis.",
"datePublished": "2022-06-21",
"url": "https://questionsmedicales.fr/article/35726824",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1242/dev.200394"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prostatic Urethral Length as a Predictor for Surgery in Benign Prostatic Hyperplasia.",
"datePublished": "2023-03-10",
"url": "https://questionsmedicales.fr/article/36974872",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.33314/jnhrc.v20i3.4613"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système immunitaire",
"item": "https://questionsmedicales.fr/mesh/D007154"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies auto-immunes",
"item": "https://questionsmedicales.fr/mesh/D001327"
},
{
"@type": "ListItem",
"position": 4,
"name": "Maladie de Basedow",
"item": "https://questionsmedicales.fr/mesh/D006111"
},
{
"@type": "ListItem",
"position": 5,
"name": "Ophtalmopathie basedowienne",
"item": "https://questionsmedicales.fr/mesh/D049970"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Ophtalmopathie basedowienne - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Ophtalmopathie basedowienne",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-04",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Ophtalmopathie basedowienne",
"description": "Comment diagnostiquer l'ophtalmopathie de Basedow ?\nQuels examens sont utilisés pour le diagnostic ?\nQuels signes cliniques indiquent cette maladie ?\nLes tests sanguins sont-ils nécessaires ?\nPeut-on confondre cette maladie avec d'autres ?",
"url": "https://questionsmedicales.fr/mesh/D049970?mesh_terms=Prostate#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Ophtalmopathie basedowienne",
"description": "Quels sont les symptômes courants ?\nLa diplopie est-elle fréquente ?\nY a-t-il des changements dans la vision ?\nComment se manifeste l'inflammation des paupières ?\nLes symptômes peuvent-ils varier d'une personne à l'autre ?",
"url": "https://questionsmedicales.fr/mesh/D049970?mesh_terms=Prostate#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Ophtalmopathie basedowienne",
"description": "Peut-on prévenir l'ophtalmopathie de Basedow ?\nLe tabagisme influence-t-il la maladie ?\nComment gérer le stress pour prévenir la maladie ?\nLes examens réguliers sont-ils importants ?\nUne alimentation saine peut-elle aider ?",
"url": "https://questionsmedicales.fr/mesh/D049970?mesh_terms=Prostate#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Ophtalmopathie basedowienne",
"description": "Quels traitements sont disponibles ?\nLes corticostéroïdes sont-ils efficaces ?\nQuand la chirurgie est-elle nécessaire ?\nLa radiothérapie est-elle courante ?\nY a-t-il des traitements non médicamenteux ?",
"url": "https://questionsmedicales.fr/mesh/D049970?mesh_terms=Prostate#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Ophtalmopathie basedowienne",
"description": "Quelles sont les complications possibles ?\nLa perte de vision est-elle réversible ?\nQuels problèmes esthétiques peuvent survenir ?\nLes nerfs optiques peuvent-ils être affectés ?\nY a-t-il des risques de complications après traitement ?",
"url": "https://questionsmedicales.fr/mesh/D049970?mesh_terms=Prostate#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Ophtalmopathie basedowienne",
"description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il le risque ?\nLes antécédents familiaux jouent-ils un rôle ?\nLe stress peut-il être un facteur de risque ?\nLes femmes sont-elles plus à risque ?",
"url": "https://questionsmedicales.fr/mesh/D049970?mesh_terms=Prostate#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer l'ophtalmopathie de Basedow ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'examen clinique, l'imagerie et des tests sanguins pour évaluer la fonction thyroïdienne."
}
},
{
"@type": "Question",
"name": "Quels examens sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les examens incluent l'échographie oculaire, l'IRM et les tests de la fonction thyroïdienne."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent cette maladie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent l'exophtalmie, la diplopie, et des modifications de la paupière."
}
},
{
"@type": "Question",
"name": "Les tests sanguins sont-ils nécessaires ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils permettent de mesurer les niveaux d'hormones thyroïdiennes et d'anticorps."
}
},
{
"@type": "Question",
"name": "Peut-on confondre cette maladie avec d'autres ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut être confondue avec d'autres causes d'exophtalmie, nécessitant un diagnostic différentiel."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent l'exophtalmie, la sécheresse oculaire, et des douleurs oculaires."
}
},
{
"@type": "Question",
"name": "La diplopie est-elle fréquente ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la diplopie est un symptôme courant, causée par l'atteinte des muscles oculaires."
}
},
{
"@type": "Question",
"name": "Y a-t-il des changements dans la vision ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des changements visuels peuvent survenir, y compris une vision floue ou double."
}
},
{
"@type": "Question",
"name": "Comment se manifeste l'inflammation des paupières ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'inflammation peut entraîner un gonflement, une rougeur et une rétraction des paupières."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils varier d'une personne à l'autre ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'intensité et la combinaison des symptômes peuvent varier considérablement."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir l'ophtalmopathie de Basedow ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode de prévention spécifique, mais contrôler la thyroïde peut aider."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il la maladie ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme aggrave les symptômes et augmente le risque d'ophtalmopathie."
}
},
{
"@type": "Question",
"name": "Comment gérer le stress pour prévenir la maladie ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion du stress peut aider à réduire les poussées de la maladie et améliorer la santé globale."
}
},
{
"@type": "Question",
"name": "Les examens réguliers sont-ils importants ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des examens réguliers permettent de détecter précocement les signes de la maladie."
}
},
{
"@type": "Question",
"name": "Une alimentation saine peut-elle aider ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée peut soutenir la santé thyroïdienne et oculaire."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent les corticostéroïdes, la radiothérapie et la chirurgie dans les cas graves."
}
},
{
"@type": "Question",
"name": "Les corticostéroïdes sont-ils efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils réduisent l'inflammation et améliorent les symptômes oculaires."
}
},
{
"@type": "Question",
"name": "Quand la chirurgie est-elle nécessaire ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chirurgie est envisagée pour corriger l'exophtalmie sévère ou les problèmes de vision."
}
},
{
"@type": "Question",
"name": "La radiothérapie est-elle courante ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle est utilisée pour traiter l'inflammation sévère des tissus orbitaires."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements non médicamenteux ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements non médicamenteux incluent des larmes artificielles et des lunettes prismatiques."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la perte de vision, l'atteinte des nerfs optiques et des problèmes esthétiques."
}
},
{
"@type": "Question",
"name": "La perte de vision est-elle réversible ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Cela dépend de la gravité de l'atteinte; certaines pertes peuvent être permanentes."
}
},
{
"@type": "Question",
"name": "Quels problèmes esthétiques peuvent survenir ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des problèmes esthétiques incluent l'exophtalmie et des modifications des paupières."
}
},
{
"@type": "Question",
"name": "Les nerfs optiques peuvent-ils être affectés ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'inflammation peut entraîner une compression des nerfs optiques, affectant la vision."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de complications après traitement ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des complications peuvent survenir même après un traitement, nécessitant un suivi."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'hyperthyroïdie, le tabagisme et des antécédents familiaux."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque augmente généralement avec l'âge, surtout chez les femmes de 30 à 50 ans."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un historique familial de maladies thyroïdiennes augmente le risque d'ophtalmopathie."
}
},
{
"@type": "Question",
"name": "Le stress peut-il être un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut déclencher ou aggraver les symptômes de l'ophtalmopathie."
}
},
{
"@type": "Question",
"name": "Les femmes sont-elles plus à risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les femmes sont plus souvent touchées par l'ophtalmopathie de Basedow que les hommes."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 23/03/2025
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
University of Health Sciences, Ulucanlar Eye Education and Research Hospital, Ankara, Turkey.
Publications dans "Ophtalmopathie basedowienne" :
4 publications dans cette catégorie
Affiliations :
University of Health Sciences, Ulucanlar Eye Education and Research Hospital, Ankara, Turkey.
Publications dans "Ophtalmopathie basedowienne" :
3 publications dans cette catégorie
Affiliations :
School of Basic Medical Science, Special Key Laboratory of Ocular Diseases of Guizhou Province, Zunyi Medical University, Zunyi, 563000, China.
Publications dans "Ophtalmopathie basedowienne" :
3 publications dans cette catégorie
Affiliations :
Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
Publications dans "Ophtalmopathie basedowienne" :
3 publications dans cette catégorie
Affiliations :
Department of Surgical, Medical and Molecular Pathology and Critical Area, University of Pisa, Pisa, Italy.
Publications dans "Ophtalmopathie basedowienne" :
3 publications dans cette catégorie
Affiliations :
Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Publications dans "Ophtalmopathie basedowienne" :
3 publications dans cette catégorie
Affiliations :
Department of Endocrinology and Metabolism, Shunde Hospital of Southern Medical University (The First People's Hospital of Shunde), Foshan, China.
The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.
Publications dans "Ophtalmopathie basedowienne" :
3 publications dans cette catégorie
Affiliations :
Biomedical Commercialization Center, Taipei Medical University, Taipei 11031, Taiwan.
Publications dans "Ophtalmopathie basedowienne" :
3 publications dans cette catégorie
Affiliations :
Department of Ophthalmology, Taipei Veterans General Hospital, Taipei 11217, Taiwan.
School of Medicine, National Yang Ming University, Taipei 11221, Taiwan.
School of Medicine, National Yang Ming Chiao Tung University, Hsinchu 30010, Taiwan.
Publications dans "Ophtalmopathie basedowienne" :
3 publications dans cette catégorie
Affiliations :
Department of Ophthalmology, National Taiwan University Hospital, Taipei 100225, Taiwan.
Publications dans "Ophtalmopathie basedowienne" :
3 publications dans cette catégorie
Affiliations :
Department of Ophthalmology, National Taiwan University Hospital, Taipei 100225, Taiwan.
Publications dans "Ophtalmopathie basedowienne" :
2 publications dans cette catégorie
Affiliations :
Department of Ophthalmology, Changzheng Hospital of Naval Medicine University, Shanghai, China.
Publications dans "Ophtalmopathie basedowienne" :
2 publications dans cette catégorie
Affiliations :
Department of Biochemistry and Pharmacogenomics, Faculty of Pharmacy, Medical University of Warsaw, Warsaw, Poland.
Laboratory of Biochemistry and Clinical Chemistry at the Centre for Preclinical Research, Medical University of Warsaw, Warsaw, Poland.
Publications dans "Ophtalmopathie basedowienne" :
2 publications dans cette catégorie
Affiliations :
Department of Internal Medicine and Endocrinology, Medical University of Warsaw, Warsaw, Poland.
Publications dans "Ophtalmopathie basedowienne" :
2 publications dans cette catégorie
Affiliations :
Chair and Department of Biochemistry, First Faculty of Medicine, Medical University of Warsaw, Warsaw, Poland.
Publications dans "Ophtalmopathie basedowienne" :
2 publications dans cette catégorie
Affiliations :
Department of Otolaryngology, Medical Center for Postgraduate Education, Warsaw, Poland.
Publications dans "Ophtalmopathie basedowienne" :
2 publications dans cette catégorie
Affiliations :
Department of Otolaryngology, Medical Center for Postgraduate Education, Warsaw, Poland.
Publications dans "Ophtalmopathie basedowienne" :
2 publications dans cette catégorie
Affiliations :
Chair and Department of Biochemistry, First Faculty of Medicine, Medical University of Warsaw, Warsaw, Poland.
Department of Otolaryngology, Medical Center for Postgraduate Education, Warsaw, Poland.
Publications dans "Ophtalmopathie basedowienne" :
2 publications dans cette catégorie
Affiliations :
Department of Ophthalmology, Third Xiangya Hospital, Central South University, Yuelu District, 138 Tongzipo Road, Changsha, 410013, Hunan, People's Republic of China.
Publications dans "Ophtalmopathie basedowienne" :
2 publications dans cette catégorie
Affiliations :
Department of Ophthalmology, Third Xiangya Hospital, Central South University, Yuelu District, 138 Tongzipo Road, Changsha, 410013, Hunan, People's Republic of China. weixiong420@csu.edu.cn.
Publications dans "Ophtalmopathie basedowienne" :
Benign prostatic hyperplasia (BPH) is the most common cause of bladder outlet obstruction in men over the age of 50 years. An association between the prostate specific antigen (PSA), International Pro...
To determine the correlation between the PSA, IPSS and PV in men of African descent....
This was a cross sectional analysis involving 92 patients diagnosed as having symptomatic BPH at the Ho Teaching Hospital....
The data were collected using standardised questionnaires. The IPSS determined urinary symptom severity. The PV was determined using a transabdominal ultrasound machine. Serum PSA was retrieved from t...
The mean PV was 61.04 cm3 ± 21.95 cm3, the mean PSA was 4.21 ng/mL ± 3.85 ng/mL, and mean IPSS of 21.59 ± 3.78. The Pearson's correlation between PV and PSA was 0.283 (p = 0.01), between PV and IPSS w...
This study showed that serum PSA has a positive correlation with PV. However, IPSS had no significant association with PSA or PV in patients with BPH.Contribution: This study provides insights into th...
We report the case of a 63-year-old male who came to the urology clinic with an increasing value of the prostate specific antigen and an asymmetrical enlargement at the digital rectal examination. The...
To compare the cost effectiveness of prostatic artery embolization (PAE) with that of transurethral resection of the prostate (TURP) for the treatment of medically refractory benign prostatic hyperpla...
A cost-effectiveness analysis with Markov modeling was performed, comparing the clinical course after PAE with that after TURP for 3 years. Probabilities were obtained from the available literature, a...
Base case calculation showed comparable outcomes (PAE, 2.845 QALY; TURP, 2.854 QALY), with a cost difference of $3,104 (PAE, $2,934; TURP, $6,038). The incremental cost-effectiveness ratio was $360,24...
PAE is a cost-effective strategy to treat medically refractory BPH, resulting in comparable health benefits at a lower cost than that of TURP even when accounting for extreme alterations in adverse ev...
Prostate organogenesis begins during embryonic development and continues through puberty when the prostate becomes an important exocrine gland of the male reproductive system. The specification and gr...
Benign prostatic hyperplasia is associated with structural and morphological changes including elongation of prostatic urethral length. The aim of our study was to assess whether prostatic urethral le...
This prospective observational study was conducted over a 12-months duration. All the patients who presented with lower urinary tract symptoms secondary to benign prostatic hyperplasia were evaluated ...
A total of 153 patients were included in the study. Eighty-three (54.2%) patients underwent surgery during the study period. Prostate volume, intravesical prostatic protrusion, post-void residual volu...
BPH patients with longer PUL may require surgical management. PUL measured by TRUS may be a predicting factor for the need of surgery in BPH Keywords: Benign prostatic hyperplasia; lower urinary tract...
Biomarkers of DNA damage repair deficiency provide opportunities for personalized treatment with immunotherapy. However, there is limited research on the immune microenvironment of adeno-neuroendocrin...
A retrospective medical record review of 66 patients with prostate cancer (PCa) was performed. PCa samples from the 66 patients were analyzed using immunohistochemical staining for the detection of ch...
Twenty patients presented with adeno-NEPC, whereas 46 presented with adeno-PCa. The median age of patients at PCa diagnosis was 67.86 ± 7.05 years (68.65 ± 7.23 years, adeno-NEPC; 67.52 ± 7.02 years, ...
Our study revealed clinicopathological manifestations of adeno-NEPC and some possible predictive factors significantly associated with better outcomes in patients with adeno-NEPC. These findings might...
The purpose of the study was to evaluate the diagnostic significance of two new and a few clinical markers for prostate cancer (PCa) at various prostate volumes (PV)....
The study subjects were divided into two groups. Among them, there were 70 cases in the PV ≤30 ml group (benign prostatic hyperplasia [BPH]: 32 cases, PCa: 38 cases) and 372 cases in the PV > 30 ml gr...
In the PV ≤30 ml group, the diagnostic parameters based on prostate-specific antigen (PSA) had a decreased diagnostic significance for PCa. In the PV > 30 ml group, PSAD (AUC = 0.709), AVR (AVR = Age/...
Choosing appropriate indicators for different PVs could contribute to the early screening and diagnosis of PCa. The difference in the diagnostic value of two new indicators (A-PSAD and AVR), and PSAD ...
Holmium laser enucleation of the prostate (HoLEP) is a size-independent surgical option for treating benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS) with excellent, durable ...
This study aims to compare the ability of the PHI versus tPSA test to predict the presence of PCa in our population....
A prospective observational study was performed. We included patients with tPSA ≥ 2.5 ng/ml, biopsy naïve or previous negative biopsy, undergoing a blood test, which includes tPSA, fPSA, and p2PSA, an...
140 men were included. Fifty-seven (40.7%) had a positive prostate biopsy result (Group A), and 83 (59.3%) had a negative biopsy result (Group B). The mean age was similar in both groups (mean ± stand...
The PHI test improves PCa detection compared to tPSA in our population....
We compare Prostate Health Index, Prostate Health Index density, and PSA density in predicting clinically significant prostate cancer in MRI-guided prostate biopsy....
This is a multicenter evaluation of prospectively maintained prostate biopsy databases at 10 urology centers. Men with Prostate Health Index and MRI-guided targeted and systematic prostate biopsy perf...
A total of 1,215 men were analyzed. Prostate cancer and clinically significant prostate cancer were diagnosed in 51% (617/1,215) and 35% (422/1,215) of men, respectively. Clinically significant prosta...
Prostate Health Index density outperformed Prostate Health Index or PSA density in clinically significant prostate cancer detection in men with multiparametric MRI performed, and further reduced unnec...